<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_AFCM-Egypt_Design skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:AFCM-Egypt/Design</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>A F C M</TITLE></P><DIV class="container" style="width:95%"><DIV class="navbar-header" style="width:100%"><BUTTON type="button" id="navbar-toggle" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON><DIV class="collapse navbar-collapse" id="navbar"><DIV class="row text-center" style="margin:auto;float:none;width:fit-content"><UL id="menu" style="float: none;
    margin-right: auto;
    margin-left: auto;
    margin-top: 0px;
    display: list-item;"><LI class="HOME"><A href="https://2017.igem.org/Team:AFCM-Egypt">HOME</A></LI><LI class="Meet"><A>TEAM </A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Meet_the_team">Meet The Team</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Collaborations">Collaborations</A></LI></UL><LI class="PROJECT"><A>PROJECT </A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Description">Project Description</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Experiments">Experiment</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Results">Results</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Demonstrate">Proof of concept</A></LI><LI class="PARTS"><A>PARTS </A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Basic_Part">Parts</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Basic_Part">Basic Parts</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Composite_Part">Composite Parts</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Improve">Improve</A></LI><LI class="Design"><A href="https://2017.igem.org/Team:AFCM-Egypt/Design">Design</A></LI><LI class="MODELING"><A href="https://2017.igem.org/Team:AFCM-Egypt/Model">MODELING</A></LI><LI class="SOFTWARE"><A href="https://2017.igem.org/Team:AFCM-Egypt/Software">Software</A></LI><LI class="SAFETY"><A href="https://2017.igem.org/Team:AFCM-Egypt/Safety">SAFETY</A></LI><LI class="HUMAN"><A>HUMAN PRACTICE </A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/HP/Silver">Silver</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/HP/Gold">Gold</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/HP/Integrated">Integrated</A></LI><LI class="ATTRIBUTIONS"><A href="https://2017.igem.org/Team:AFCM-Egypt/Attributions">ATTRIBUTIONS</A></LI><LI class="CRITERIA"><A href="https://2017.igem.org/Team:AFCM-Egypt/Medal_criteria">MEDAL CRITERIA</A></LI></DIV></DIV></DIV></DIV><P><TITLE>A F C M</TITLE></P><DIV class="container section-wrapper"><DIV class="row" style="margin-bottom: 50px;"><DIV class="col-md-6 text-center" style="float: none; margin: auto; width: 82%; background-color: rgba(181, 178, 173, 0.4);"><P style="text-align: center;"><SPAN style="font-size: 28pt; line-height: 107%; font-family: Calibri, sans-serif; background-color: #ffcc00;"><SPAN style="background-color: #999999;"><EM><SPAN style="font-family: 'times new roman', times;">Biomarker Filtration</SPAN></EM></SPAN></SPAN></P><P style="text-align: center;"><EM><SPAN style="text-decoration: underline;"><SPAN style="font-size: 19pt; font-family: 'times new roman', times;">Steps Of Our Biomarker filtration </SPAN></SPAN></EM></P><P style="text-align: center;"><SPAN style="color: #ffffff;"><STRONG><SPAN style="font-size: 30pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif;">Design</SPAN></STRONG></SPAN></P><P style="text-align: justify;"> </P><P style="text-align: center;"><SPAN style="font-size: 15pt; color: #ffffff;"><STRONG><SPAN style="line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Our design aims to compare the function of both circuits at regulating non-coding RNAs</SPAN></STRONG></SPAN></P><P style="text-align: center;"><SPAN style="color: #000000;"> </SPAN></P><P style="text-align: center;"><SPAN style="font-size: 28pt; line-height: 107%; font-family: Calibri, sans-serif; color: #000000;"> </SPAN></P><TABLE style="height: 80px; border-color: #f21111; margin-left: auto; margin-right: auto;"><TBODY><TR><TD style="width: 463px; text-align: center;"><SPAN style="font-family: 'times new roman', times; font-size: 17pt; color: #ffffff;"><STRONG>CRISPR circuit</STRONG></SPAN></TD><TD style="width: 534px; text-align: center;"><SPAN style="font-size: 17pt; color: #ffffff;"><STRONG><SPAN style="font-family: 'times new roman', times;">ceRNA circuit</SPAN></STRONG></SPAN></TD></TR><TR style="text-align: center;"><TD style="width: 463px;"><P style="text-align: center;"><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'times new roman', times; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><STRONG>BBa_K2217026</STRONG></SPAN></SPAN></P></TD><TD style="width: 534px;"><P style="text-align: center;"><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">BBa_K2217025</SPAN></SPAN></P></TD></TR></TBODY></TABLE><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Fig-1 Composite Part BBa_K2217018</SPAN></P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #282828; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="color: #ffffff;">Part BBa_K2217018 was composed of  U6</SPAN><SPAN style="color: #000000;"><SPAN style="color: #ffffff;"> (</SPAN><SPAN style="color: #ff9900;">BBa_K2217002</SPAN><SPAN style="color: #ffffff;">) as a promoter for gRNA (</SPAN><SPAN style="color: #ff9900;">BBa_K2217003</SPAN><SPAN style="color: #ffffff;">)(Designed using MIT CRISPR web tool according to the addgene protocol).<SUP>[1][2] </SUP>The gRNA needs a scaffold to guide the Cas9 (</SPAN><SPAN style="color: #ff9900;">BBa_K2217004</SPAN><SPAN style="color: #ffffff;">) and finally it was terminated by SV40 poly(A) signal Termination (</SPAN><SPAN style="color: #ff9900;">BBa_K2217005</SPAN><SPAN style="color: #ffffff;">).</SPAN></SPAN></SPAN></P><P style="text-align: center;"><SPAN style="color: #000000;"> </SPAN></P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #282828; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="color: #ffffff;">Fig-2 Composite Part BBa_K2217019</SPAN></SPAN></P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #282828; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="color: #000000;"><SPAN style="color: #ffffff;">Part</SPAN></SPAN><SPAN style="color: #ff9900;">BBa_K2217019</SPAN><SPAN style="color: #ffffff;"> was composed of CMV Enhancer as well as CMV Promoter (</SPAN><SPAN style="color: #ff9900;">BBa_K2217000</SPAN><SPAN style="color: #000000;"><SPAN style="color: #ffffff;">and </SPAN></SPAN><SPAN style="color: #ff9900;">BBa_K2217006</SPAN><SPAN style="color: #ffffff;"> respectively) as constitutive promoters to enhance the transcription process of the Cas9 (</SPAN><SPAN style="color: #ff9900;">BBa_K1218011</SPAN><SPAN style="color: #ffffff;">) part which was transcribed using  T7 Promoter (</SPAN><SPAN style="color: #ff9900;">BBa_K2217007</SPAN><SPAN style="color: #ffffff;">) following Protocol<SUP>[3]</SUP>. The design aimed at generating Homology Directed Repair instead of Non-Homologous end Joining repair of Cas9 by knocking in the circular RNA as a Competing endogenous RNA enhancing its transcription to regulate miRNA action, so we designed Homology repair template (</SPAN><SPAN style="color: #ff9900;">BBa_K2217009</SPAN><SPAN style="color: #ffffff;">) to be transfected on a separate donor vector then terminated with CYC1 terminator(</SPAN><SPAN style="color: #ff9900;">BBa_K2217008</SPAN></SPAN><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">).</SPAN></P><P style="text-align: center;"> </P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #282828; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="color: #ffffff;">Fig-3 Composite Part BBa_K2217020</SPAN></SPAN></P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #282828; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="color: #ffffff;">In order to enhance transcription of the circular RNA as a competing endogenous RNA in a ceRNA network, we used the CAG promoter composed of CMV enhancer and Chicken B-actin Promoter</SPAN><SPAN style="color: #ffffff;">(</SPAN><SPAN style="color: #ff9900;">BBa_K2217013</SPAN><SPAN style="color: #ffffff;">) while circular RNA (hsa-circ-0000064) was submitted to the registry after biomarker filtration using bioinformatics databases demonstrated at our </SPAN></SPAN><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">biomarker filtration</SPAN> <SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> page</SPAN></SPAN><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #282828; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="color: #ffffff;"> (</SPAN><SPAN style="color: #ff9900;">BBa_K2217001</SPAN><SPAN style="color: #ffffff;">). Finally it was terminated by SV40 poly(A) signal Termination (</SPAN><SPAN style="color: #ff9900;">BBa_K2217005</SPAN><SPAN style="color: #ffffff;">).</SPAN></SPAN></P><P style="text-align: center;"> <SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Fig-4 Composite Part BBa_K2217022</SPAN></SPAN></P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #282828; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="color: #ffffff;">Part</SPAN><SPAN style="color: #ff9900;">BBa_K2217022</SPAN><SPAN style="color: #ffffff;">was composed of CMV Enhancer as well as CMV Promoter (</SPAN><SPAN style="color: #ff9900;">BBa_K2217000</SPAN><SPAN style="color: #ffffff;">and </SPAN><SPAN style="color: #ff9900;">BBa_K2217006</SPAN><SPAN style="color: #ffffff;">respectively) as constitutive promoters to enhance the transcription process of the laci that was submitted (</SPAN><SPAN style="color: #ff9900;">Ba_K2217012</SPAN><SPAN style="color: #ffffff;">). We also improved the fragment’s characterization by adding the miRNA binding site of the miRNA mir-1825 as determined computationally using circ interactome database <SUP>[4]</SUP> where we hypothesised its function as a trigger for miRNA binding and synthesis. Finally, it was terminated by SV40 poly(A) signal Termination (</SPAN><SPAN style="color: #ff9900;">BBa_K2217005</SPAN><SPAN style="color: #ffffff;">).</SPAN></SPAN></P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Fig-5 Composite Part BBa_K2217023</SPAN></P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #282828; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="color: #ffffff;">Part</SPAN><SPAN style="color: #ff9900;">BBa_K2217023</SPAN><SPAN style="color: #ffffff;"> is composed of lac operator (</SPAN><SPAN style="color: #ff9900;">BBa_K2217016</SPAN><SPAN style="color: #ffffff;">) and the lac promoter (</SPAN><SPAN style="color: #ff9900;">BBa_K2217017</SPAN><SPAN style="color: #ffffff;">) as a weak constitutive promoter in a trial to improve characterization of ceRNA network using yfb (</SPAN><SPAN style="color: #ff9900;">BBa_K2217014</SPAN><SPAN style="color: #ffffff;">) detection using flow cytometry. Finally, it was terminated by Poly_gh termination (</SPAN><SPAN style="color: #ff9900;">BBa_K2217015</SPAN><SPAN style="color: #ffffff;">).</SPAN></SPAN></P><P><SPAN style="font-size: 14.0pt; line-height: 115%; font-family: 'Trebuchet MS','sans-serif'; color: #282828; background: white;"> </SPAN></P><P style="text-align: center;"><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">All Parts were designed in SBOL format using SBOLDesigner.<SUP>[5]</SUP> Sequence editing was performed on Benchling<SUP>[6]</SUP> and composites were constructed in synthetic<SUP>TM</SUP> Language using cytostudio.<SUP>[7]</SUP></SPAN></SPAN></P><P style="text-align: center;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><SPAN style="text-decoration: underline;"><STRONG>References</STRONG></SPAN></SPAN></P><P><SPAN style="font-size: 14.0pt; line-height: 115%; font-family: 'Trebuchet MS','sans-serif'; color: #282828; background: white;"> </SPAN></P><P><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[1] </SPAN><A style="color: #ffffff;" href="http://crispr.mit.edu"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">http://crispr.mit.edu</SPAN></A></SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[2] </SPAN><A style="color: #ffffff;" href="https://media.addgene.org/cms/files/hCRISPR_gRNA_Synthesis.pdf"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">https://media.addgene.org/cms/files/hCRISPR_gRNA_Synthesis.pdf</SPAN></A></SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[3] </SPAN><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Romanienko PJ, Giacalone J, Ingenito J, et al. A Vector with a Single Promoter for <EM>In Vitro</EM> Transcription and Mammalian Cell Expression of CRISPR gRNAs. Fujii H, ed. <EM>PLoS ONE</EM>. 2016;11(2):e014836.</SPAN></SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[4] </SPAN><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. <EM>RNA Biology</EM>. 2016;13(1):34-42. </SPAN></SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[5] </SPAN><A style="color: #ffffff;" href="http://www.async.ece.utah.edu/SBOLDesigner"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">www.async.ece.utah.edu/SBOLDesigner</SPAN></A></SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[6] </SPAN><A style="color: #ffffff;" href="https://benchling.com/"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">https://benchling.com/</SPAN></A></SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="color: #ffffff;"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[7] </SPAN><A style="color: #ffffff;" href="https://moleculamaxima.com/"><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">https://moleculamaxima.com/</SPAN></A></SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P><P><SPAN style="font-size: 14pt; line-height: 115%; font-family: 'Trebuchet MS', sans-serif; color: #ffffff; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </SPAN></P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>